Frontlight ResearchEarly access
CompletedNo phase
Regulatory Post-Marketing Surveillance of Xolair® for Chronic Rhinosinusitis With Nasal Polyps
Key facts
- Who runs it
- Novartis Pharmaceuticals
- Where
- South Korea8 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 135 people enrolled
- Started
- 12 Jan 2023
- Ended
- 15 Apr 2025
- Type of study
- Observational
- Treatments tested
- Xolair
- Record updated
- 29 May 2026
Who can take part
- Age
- 18 years to 100 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Adults aged ≥18 years
- Patients with CRSwNP who are not adequately controlled with conventional therapy (INCS)
- Patients prescribed with Xolair® as per the locally approved label information
- Patients who provide written informed consent to participate in the study
Who cannot take part
- Contraindications listed in the locally approved label information of Xolair®; Hypersensitivity to the active ingredient or any other ingredient of Xolair®; Patients with myocardial infarction or history of myocardial infarction (pre-filled syringes only)
- Patients who do not provide consent to participate in the study
- Patients participating in other clinical trial
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study aims to evaluate the safety and effectiveness of Xolair® in patients with chronic rhinosinusitis with nasal polyps in routine clinical practice.
The group in the trial
- Xolair
patients who prescribed with Xolair according to the current label information in Korea.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Regulatory Post-Marketing Surveillance (rPMS) of Xolair® (Xolair® 150mg Powder for Solution for Injection, Xolair® 150mg/1ml Liquid in Pre-filled Syringe, Xolair® 75mg/0.5ml Liquid in Pre-filled Syringe) for Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
- Record updated
- 29 May 2026